Skip to main content
D. Ware Branch
( out of 43 reviews )

D. Ware Branch, MD

Languages spoken: English

Clinical Locations

Primary Location

South Jordan Health Center

Women's Health Services
5126 West Daybreak Parkway
South Jordan , UT 84009

University of Utah Hospital

University Maternal Fetal Medicine, Area E
50 N Medical Dr
Salt Lake City , UT 84132

Sugar House Health Center

Women's Health Services
1280 E. Stringham Avenue
Salt Lake City , UT 84106

Dr. Ware Branch has a passion for helping those who face complex pregnancy challenges and cares for his patients experiencing high-risk pregnancies. As a specialist in maternal-fetal medicine, Dr. Branch specializes in managing various conditions, including recurrent miscarriage, genetics and fetal diagnosis, placenta accreta, and stillbirth. He is committed to achieving the best possible outcomes for his patients and is here to support you and your family every step of the way through your pregnancy journey.

Dr. Branch is currently accepting new patients. Please call to schedule an appointment or for more information.

Dr. Branch has been dedicated to high-risk pregnancies since 1985, when he completed his fellowship in maternal-fetal medicine at the University of Utah and completed specialty training.

He now leads the fellowship program, passing on his knowledge and experience to the next generation of doctors. He is also a professor of obstetrics and gynecology at the Spencer Fox Eccles School of Medicine at the University of Utah and serves as the medical director of the women and newborn clinical program for the urban central region of Intermountain Health.

Dr. Branch is internationally recognized for his research and expertise in managing conditions like antiphospholipid syndrome (APS), thrombotic disorders during pregnancy, and recurrent pregnancy loss.

Patient Rating

Patients frequently note the physician is knowledgeable, thorough, and communicates information directly, with many reporting they feel well informed and confident in his care. However, several patients described poor bedside manner, feeling dismissed or belittled during visits, and one reported the fellow provided more attentive care than the physician. A number of comments also raised operational concerns about long waits without updates and unprofessional staff behavior in the waiting area.

Generated via Patient Reviews

4.4 /5
( out of 43 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


Feb 20, 2026
SOUTH JORDAN HEALTH CENTER

I really appreciate his honesty and laid back energy. He listens and is willing to work with me through my pregnancy rather than tell me how my pregnancy gets to be with little to no input from me. He's knowledgeable and experienced without being arrogant and pushy. So far, out of 11 pregnancies, he is my favorite OB and I wish I had found him sooner.

Nov 12, 2025
UNIVERSITY HOSPITAL

Dr Branch is brilliant. He is very smart! Answers every question I have respectfully. Knowing I'm a scared mom he keeps his composure and eases my anxiety with educated answers. He doesn't guess he runs all the test to give me a solid answer. Will highly recommend to everyone in my position.

Aug 28, 2025
UNIVERSITY HOSPITAL

Very pleased with Dr. Branch's bedside manner. He also was a perfect mix of concerned but reassuring about my issues.

Aug 13, 2025
UNIVERSITY HOSPITAL

I felt like Dr Branch really took a lot of time and care with my appointment and I appreciated how much he tried to ensure that I felt comfortable and empowered to make decisions or take next steps.

May 23, 2025
SOUTH JORDAN HEALTH CENTER

Dr. Branch is a great doctor. He looks at each situation and determines the best course of action based on the specific patient and not ÒthatÕs how itÕs always done.Ó

Mar 25, 2025
SOUTH JORDAN HEALTH CENTER

I appreciated Dr Branch's approach to my care because, while direct, he was also friendly and respectful and really took the time to get to know me. Other doctors made judgements based off of appearances, but he digs deeper to really learn about his patients to offer the best care possible. I've only had one visit, but I'm confident Dr Branch will offer the care I've been looking for.

Mar 22, 2025
SOUTH JORDAN HEALTH CENTER

Dr. Branch is great at being proactive about my healthcare. He's got a plan for best and worst case scenarios and makes sure we are on the same page and I'm good with the plan. He follows the research and even showed me where I can look at the most updated research for my condition.

Dec 03, 2024
SOUTH JORDAN HEALTH CENTER

I did NOT like my experience. I seen Dr. Branch while my usual obstetrician was out of town. Dr. Branch made me feel belittled and dumb throughout my appointment. He did not have a good bedside manner, and his attitude was poor. As a first time mom, this was a terrible experience. He did not address any of my questions or concerns. This is especially concerning since I am a high risk pregnancy, and had concerning issues I wanted to address. He deflected my questions and turned them into talks about diet and exercise. I had to message my usual Doctor to get information from my appointment. I didn't even know I had been diagnosed with gestational hypertension until messaging my doctor for clarification. I will NOT be seeing Dr. Branch again, and I do not recommend him to others. His dismissive attitude should not be working with pregnant women, and he should probably retire.

Oct 18, 2024
SOUTH JORDAN HEALTH CENTER

Dr.Branch really cares about your success and wants the best for you! He's really great!

Oct 18, 2024
SOUTH JORDAN HEALTH CENTER

Dr Branch is very nice and caring. He truely was concern for us.

Jun 08, 2024
SUGAR HOUSE HEALTH CENTER

I feel confident in the care I receive from Dr. Branch. He is detailed in answering my questions and straightforward. I know he is a very busy provider, but he never makes me feel rushed during the appointments. I'm fortunate that he has been my provider for both my pregnancies. Thank you Dr. Branch for all you do for the T1D community!!

May 26, 2024
UH HOSPITALS AND CLINICS

Dr. Branch is amazing! I would highly recommend him. I trust him to provide me with the best care!

May 01, 2024
UH HOSPITALS AND CLINICS

Dr Branch had a positive vibe which made me comfortable to share my health concerns. He is a great communicator.

Apr 21, 2024
SOUTH JORDAN HEALTH CENTER

He is a great doctor. Very good at his job. But continues to treat me like a child. He calls me "kid" everytime I see him. He also continues to lecture me on my eating habits, drinking coffee, working out, etc.

Apr 04, 2024
UH HOSPITALS AND CLINICS

Dr.Branch is very professional and attentive. He answers all questions and gives clear instructions.

Mar 27, 2024
UH HOSPITALS AND CLINICS

He took the time to explain things that doctors I. The past had not. He seemed calm and not rushed. He answered all our questions and his answers were all research based. He was warm and compassionate as well.

Feb 24, 2024
SUGAR HOUSE HEALTH CENTER

Dr Branch makes sure your questions and concerns are addressed. He is a dr with zero filter and that's exactly what I wanted, to make sure I'm 100% aware of what can do to make sure my pregnancy and baby are healthy.

Nov 15, 2023
UH HOSPITALS AND CLINICS

He seemed very interested in understanding my pregnancy history so I can have a successful pregnancy.

Jul 12, 2023
UH HOSPITALS AND CLINICS

He is normally not my doctor, but Im so grateful to have seen him during a difficult situation. He gave me great advice and showed he cared about my health. I hope to be under his care if Im able to have another baby. Excellent doctor that I would highly recommend.

May 11, 2023
UH HOSPITALS AND CLINICS

Dr. Ware Branch was wonderful to work with. He had a good grasp on my health history, and took the time to explain all of the different options I had. He made sure that I understood what he was saying. He was very encouraging and kind.

May 03, 2023
UH HOSPITALS AND CLINICS

Hes down to earth and respectful.

Apr 13, 2023
UH HOSPITALS AND CLINICS

Dr. Branch was great in explaining my pregnancy-related issue and the possibilities. I was a bit nervous but he made us feel comfortable. I highly recommend Dr. Branch if you are looking for a perinatologist.

Dec 25, 2022
SUGAR HOUSE HEALTH CENTER

El es un doctor asombroso siempre nos encanta tomar las citas con el porque nos dise muy bien toda las cosas de manera que no pueda haber duda

Aug 07, 2022
SUGAR HOUSE HEALTH CENTER

Dr branch is a very straightforward, no-nonsense guy. That being said I always feel like we're on the same side and that he's making sure I'm on the team. I'm a fan.

Oct 17, 2021
SUGAR HOUSE HEALTH CENTER

Dr. Branch was patronizing. He knows his stuff but his approach isn't for me. I don't like to be treated like I'm stupid.

Jun 06, 2021
SUGAR HOUSE HEALTH CENTER

Dr. Branch spent way more time with me than I expected. He took the time to get my full background and explained the risks to my pregnancy and how he was going to make it as safe as possible.

Apr 20, 2021
UH HOSPITALS AND CLINICS

Dr. Branch and his student were great- they were clear in disseminating information, they answered all of our questions and spent time with us to make sure we had all the information we needed.

Apr 18, 2021
SUGAR HOUSE HEALTH CENTER

This was my first visit with Dr. Branch. I am so excited to have him as my Dr for this pregnancy. He listened to me and I felt supported and heard.

Feb 04, 2021
UH HOSPITALS AND CLINICS

Dr Branch is absolutely phenomenal. We have finally found a doctor who genuinely cares.

Sep 08, 2020
UH HOSPITALS AND CLINICS

very straightforward and honest


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Dr. Ware Branch has a passion for helping those who face complex pregnancy challenges and cares for his patients experiencing high-risk pregnancies. As a specialist in maternal-fetal medicine, Dr. Branch specializes in managing various conditions, including recurrent miscarriage, genetics and fetal diagnosis, placenta accreta, and stillbirth. He is committed to achieving the best possible outcomes for his patients and is here to support you and your family every step of the way through your pregnancy journey.

Dr. Branch is currently accepting new patients. Please call to schedule an appointment or for more information.

Dr. Branch has been dedicated to high-risk pregnancies since 1985, when he completed his fellowship in maternal-fetal medicine at the University of Utah and completed specialty training.

He now leads the fellowship program, passing on his knowledge and experience to the next generation of doctors. He is also a professor of obstetrics and gynecology at the Spencer Fox Eccles School of Medicine at the University of Utah and serves as the medical director of the women and newborn clinical program for the urban central region of Intermountain Health.

Dr. Branch is internationally recognized for his research and expertise in managing conditions like antiphospholipid syndrome (APS), thrombotic disorders during pregnancy, and recurrent pregnancy loss.

Board Certification and Academic Information

Academic Departments Obstetrics & Gynecology -Professor
Academic Divisions Maternal Fetal Medicine

Education history

Undergraduate Biology - University of Richmond B.S.
Professional Medical Medicine - Medical College of Virginia M.D.
Internship OB/GYN - Medical College of Virginia Hosp. Intern
Residency OB/GYN - Medical College of Virginia Hospital Resident
Fellowship Maternal/Fetal Medicine - University of Utah School of Medicine Fellow

Selected Publications

Journal Article

  1. Bruno AM, Job KM, Rower JE, Allshouse AA, Zinkhan EK, Lim MY, Shakib JH, Federspiel JJ, Watt KM, Metz TD, Branch D (2026). Prophylactic-Dose Rivaroxaban Transfer Into Human Milk. Obstetrics and gynecology, 147(5), e116-e119.
  2. Barbhaiya M, Zuily S, Jannat-Khah D, Amigo MC, Andrade D, Avcin T, Bertolaccini ML, Branch DW, Costedoat-Chalumeau N, de Jesús GR, Devreese KMJ, Garcia D, Gomez Puerta JA, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Petri M, Sanna G, Sciascia S, Seshan SV, Tektonidou M, Wahl D, Willis R, Yelnik C, Hendry A, Naden R, Costenbader KH, Erkan D, New APS Classification Criteria Collaborator (2026). Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions. Arthritis care & research, 78(5), 563-573.
  3. Thaler J, Parides M, de Andrade DCO, Ruiz DP, Tektonidou MG, Pengo V, Sciascia S, Nalli C, de Jesús G, Fortin PR, Efthymiou M, Belmont HM, Petri M, Cervera R, Skeith L, Atsumi T, López-Pedrera C, Zuo Y, Branch DW, Willis R, Kello N, Zhang Z, Almaraz ER, Artim-Esen B, Pardos-Gea J, Pons-Estel G, Pazzola G, Shi H, Duarte-Garcia A, Barbhaiya M, Yelnik C, Meroni P, Roubey R, Bertolaccini ML, Cohen H, Rand JH, Erkan (2026). Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry'). Annals of the rheumatic diseases, 85(3), 497-506.
  4. Workalemahu T, Madsen MJ, Lopez S, Page JM, Blue NR, Avery C, Sargent R, Yu Z, Guinto E, Branch DW, Leisher S, Jorde LB, Quinlan A, Coon H, Varner MW, Roberts CT, Neklason DW, Camp NJ, Silver R (2026). Inherited genetic risk in stillbirth: A shared genomic segments analysis of high-risk pedigrees. HGG advances, 7(1), 100546.
  5. Pine A, Butt A, Andreoli L, Knight JS, Gerosa M, Cecchi I, Branch DW, Lopez-Pedrera R, Belmont HM, Kello N, Petri M, Cervera R, Pengo V, Meroni PL, Cohen H, Willis R, Bertolaccini ML, Goshua G, Gu S, Hwa J, Lee AI, Erkan D, Sharda A (2025). A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry. Frontiers in immunology, 16, 1676578.
  6. Bruno AM, Allshouse AA, Branch DW, Silver RM, Metz T (2025). Low Molecular Weight Heparin Thromboprophylaxis or No Treatment following Cesarean Delivery: A Pilot Randomized Controlled Trial. American journal of perinatology,
  7. Branch DW, Kim MY, Guerra MM, Worden J, Laskin CA, DeSancho MT, Landres IV, Knight JS, Slosberg HS, Minett M, Salmon J (2025). Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial. Annals of the rheumatic diseases, 84(6), 1011-1022.
  8. Yelnik CM, Erton ZB, Drumez E, Cheildze D, de Andrade D, Clarke A, Tektonidou MG, Sciascia S, Pardos-Gea J, Pengo V, Ruiz-Irastorza G, Belmont HM, Pedrera CL, Fortin PR, Wahl D, Gerosa M, Kello N, Signorelli F, Atsumi T, Ji L, Efthymiou M, Branch DW, Nalli C, Rodriguez-Almaraz E, Petri M, Cervera R, Shi H, Zuo Y, Artim-Esen B, Pons-Estel G, Willis R, Barber MRW, Skeith L, Bertolaccini ML, Cohen H, Roubey R, Erkan (2024). Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry"). Seminars in arthritis and rheumatism, 65, 152347.
  9. Lim MY, Rodgers GM, Branch DW, Simonsen S (2024). Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single-institution cohort study. Haemophilia, 30(2), 470-477.
  10. Branch DW, Lim M (2024). How I diagnose and treat antiphospholipid syndrome in pregnancy. Blood, 143(9), 757-768.
  11. Zhu H, Lu D, Branch DW, Troendle J, Tang Y, Bernitz S, Zamora J, Betran AP, Zhou Y, Zhang (2024). Oxytocin is not associated with postpartum hemorrhage in labor augmentation in a retrospective cohort study in the United States. American journal of obstetrics and gynecology, 230(2), 247.e1-247.e9.
  12. Zuo Y, Navaz S, Tsodikov A, Kmetova K, Kluge L, Ambati A, Hoy CK, Yalavarthi S, de Andrade D, Tektonidou MG, Sciascia S, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin PR, de Jesus GR, Branch DW, Andreoli L, Rodriguez-Almaraz E, Petri M, Cervera R, Willis R, Karp DR, Li QZ, Cohen H, Bertolaccini ML, Erkan D, Knight JS, Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networkin (2023). Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository. Arthritis & rheumatology (Hoboken, N.J.), 75(8), 1407-1414.
  13. Branch DW, VanBuren JM, Porter TF, Holmgren C, Holubkov R, Page K, Burchard J, Lam GK, Esplin M (2023). Prediction and Prevention of Preterm Birth: A Prospective, Randomized Intervention Trial. American journal of perinatology, 40(10), 1071-1080.
  14. Balbi GGM, Ahmadzadeh Y, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Lopez-Pedrera C, Fortin PR, Wahl D, Gerosa M, de Jesús GR, Ji L, Atsumi T, Efthymiou M, Branch DW, Nalli C, Almaraz ER, Petri M, Cervera R, Knight JS, Artim-Esen B, Willis R, Bertolaccini ML, Cohen H, Roubey R, Erkan D, Andrade D, AntiPhospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (APS ACTION (2023). Damage measured by damage index for antiphosphlipid syndrome in antiphospholipid antibody-positive patients included in APS ACTION Registry. Rheumatology (Oxford, England),
  15. Gkrouzman E, Willis R, Andrade D, Tektonidou MG, Pengo V, Ruiz-Irastorza G, Belmont HM, Fortin PR, Gerosa M, Signorelli F, Atsumi T, Branch DW, Nalli C, Rodriguez-Almaraz E, Petri MA, Cervera R, Knight JS, Efthymiou M, Cohen H, Bertolaccini ML, Erkan D, Roubey R, APS ACTIO (2023). Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study. Laboratory investigation; a journal of technical methods and pathology, 103(6), 100147.
  16. Chighizola CB, Pregnolato F, Andrade D, Tektonidou M, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin P, Branch DW, Andreoli L, Petri MA, Cervera R, Knight JS, Willis R, Efthymiou M, Cohen H, Erkan D, Bertolaccini ML, Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION (2023). Fluctuation of Anti-Domain 1 and Anti-ß(2) -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies. Arthritis & rheumatology (Hoboken, N.J.), 75(6), 984-995.
  17. Einerson BD, Kennedy A, Silver RM, Branch DW, Comstock J, Woodward P (2023). Ultrasonography of the Explanted Uterus in Placenta Accreta Spectrum: Correlation With Intraoperative Findings and Gross Pathology. Obstetrics and gynecology, 141(3), 544-554.
  18. Dude AM, Smid MC, Branch DW, West J, Meeks H, Yu Z, Fraser A, Smith K, Reddy (2023). Interpregnancy Body Mass Index Change and Offspring Mortality Risk following the Second Pregnancy. American journal of perinatology, 40(4), 387-393.
  19. Workalemahu T, Avery C, Lopez S, Blue NR, Wallace A, Quinlan AR, Coon H, Warner D, Varner MW, Branch DW, Jorde LB, Silver R (2023). Whole-genome sequencing analysis in families with recurrent pregnancy loss: A pilot study. PloS one, 18(2), e0281934.
  20. Mehta B, Jannat-Khah D, Glaser KK, Luo Y, Sammaritano LR, Branch DW, Goodman SM, Lockshin M, Wang F, Ibrahim S, Salmon J (2023). Fetal and maternal morbidity in pregnant patients with Lupus: a 10-year US nationwide analysis. RMD open, 9(1),
  21. Lim MY, Abou-Ismail MY, Branch D (2023). Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum. Obstetrics and gynecology, 141(1), 85-108.
  22. Young A, Lim MY, Sanders J, Branch DW, Simonsen S (2023). Pregnancy and childbirth in women with bleeding disorders: A retrospective cohort study. Haemophilia, 29(1), 240-247.
  23. Bruno AM, Allshouse AA, Benson AE, Yost CC, Metz TD, Varner MW, Silver RM, Branch D (2023). Thrombotic Markers in Pregnant Patients with and without SARS-CoV-2 Infection. American journal of perinatology, 41(S 01), e3202-e3209.
  24. Parks AL, Fazili M, Aston V, Porter TF, Branch DW, Woller SC, Snow GL, Stevens S (2023). Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound. Research and practice in thrombosis and haemostasis, 7(7), 102202.
  25. Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesús G, Delluc A, Desai S, Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-García A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D, ACR/EULAR APS Classification Criteria Collaborator (2023). 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Annals of the rheumatic diseases, 82(10), 1258-1270.
  26. Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesus G, Delluc A, Desai S, De Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garcia A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D, ACR/EULAR APS Classification Criteria Collaborator (2023). The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis & rheumatology (Hoboken, N.J.), 75(10), 1687-1702.
  27. Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson B (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstetrics and gynecology, 140(5), 806-811.
  28. Bruno AM, Allshouse AA, Campbell HM, Branch DW, Lim MY, Silver RM, Metz T (2022). Weight-Based Compared With Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial. Obstetrics and gynecology, 140(4), 575-583.
  29. Erton ZB, Sevim E, de Jesús GR, Cervera R, Ji L, Pengo V, Ugarte A, Andrade D, Andreoli L, Atsumi T, Fortin PR, Gerosa M, Zuo Y, Petri M, Sciascia S, Tektonidou MG, Aguirre-Zamorano MA, Branch DW, Erkan D, APS ACTIO (2022). Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry'). Lupus science & medicine, 9(1),
  30. Woller SC, Stevens SM, Kaplan D, Wang TF, Branch DW, Groat D, Wilson EL, Armbruster B, Aston VT, Lloyd JF, Rondina MT, Elliott C (2022). Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood advances, 6(6), 1661-1670.
  31. Givens M, Einerson BD, Allshouse AA, Bruno AM, Hammad I, Debbink MP, Branch DW, Silver R (2022). Trends in Unplanned Peripartum Hysterectomy in the United States, 2009-2020. Obstetrics and gynecology, 139(3), 449-451.
  32. Sevim E, Zisa D, Andrade D, Sciascia S, Pengo V, Tektonidou MG, Ugarte A, Gerosa M, Belmont HM, Zamorano MAA, Fortin PR, Ji L, Efthymiou M, Cohen H, Branch DW, de Jesus GR, Andreoli L, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Roubey R, Bertolaccini ML, Erkan D, Barbhaiya M, APS ACTION Investigator (2022). Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository. Arthritis care & research, 74(2), 324-335.
  33. Arslan E, Einerson BD, Zhang J, Zhang J, Branch D (2021). The Effect of "Off Hours" on Maternal and Perinatal Outcomes in a Diverse U.S. Cohort. American journal of perinatology, 41(1), 89-97.
  34. de Azevedo Lopes E, Balbi GGM, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Gerosa M, Fortin PR, Lopez-Pedrera C, Ji L, Cohen H, de Jesús GR, Branch DW, Nalli C, Petri M, Rodriguez E, Kello N, Ríos-Garcés R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Erkan D, Andrade D, APS ACTIO (2021). Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository. Advances in rheumatology (London, England), 61(1), 64.
  35. Gkrouzman E, Sevim E, Finik J, Andrade D, Pengo V, Sciascia S, Tektonidou MG, Ugarte A, Chighizola CB, Belmont HM, Lopez-Pedrera C, Ji L, Fortin P, Efthymiou M, de Jesus GR, Branch DW, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Cohen H, Rand J, Erkan D, APS ACTION (2021). Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository. The Journal of rheumatology, 48(4), 541-547.
  36. Carey AZ, Blue NR, Varner MW, Page JM, Chaiyakunapruk N, Quinlan AR, Branch DW, Silver RM, Workalemahu (2021). A systematic review to guide future efforts in the determination of genetic causes of pregnancy loss. Frontiers in reproductive health, 3,
  37. Paidas MJ, Tita ATN, Macones GA, Saade GA, Ehrenkranz RA, Triche EW, Streisand JB, Lam GK, Magann EF, Lewis DF, Dombrowski MP, Werner EF, Branch DW, Habli MA, Grotegut CA, Silver RM, Longo SA, Amon E, Cleary KL, How HY, Novotny SR, Grobman WA, Whiteman VE, Wing DA, Scifres CM, Sibai B (2020). Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia. American journal of obstetrics and gynecology, 223(5), 739.e1-739.e13.
  38. Zuily S, Clerc-Urmès I, Bauman C, Andrade D, Sciascia S, Pengo V, Tektonidou MG, Ugarte A, Gerosa M, Michael Belmont H, Zamorano MAA, Fortin P, Ji L, Efthymiou M, Cohen H, Branch DW, Jesus GR, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Vega J, Wahl D, Erkan D, APS ACTION Investigator (2020). Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry. Lupus, 29(11), 1353-1363.

Review

  1. Chighizola CB, Willis R, Maioli G, Sciascia S, Andreoli L, Amengual O, Radin M, Gerosa M, Atsumi T, de Jesus G, Trespidi L, Branch DW, Caporali R, Andrade D, Roubey R, Petri M, Bertolaccini M (2024). Deciphering the clinical significance of longitudinal antiphospholipid antibody titers. Autoimmunity reviews, 23(3), 103510.
  2. Knight JS, Branch DW, Ortel T (2023). Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ (Clinical research ed.), 380, e069717.
  3. Barbhaiya M, Zuily S, Ahmadzadeh Y, Amigo MC, Avcin T, Bertolaccini ML, Branch DW, de Jesus G, Devreese KMJ, Frances C, Garcia D, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Seshan SV, Tektonidou M, Wahl D, Willis R, Naden R, Costenbader K, Erkan D, New APS Classification Criteria Collaborator (2021). Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria. Arthritis care & research, 73(10), 1490-1501.
  4. de Jesús GR, Benson AE, Chighizola CB, Sciascia S, Branch D (2020). 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome. Lupus, 29(12), 1601-1615.
  5. Welsch S, Branch D (1997). Antiphospholipid syndrome in pregnancy. Obstetric concerns and treatment. Rheumatic diseases clinics of North America, 23(1), 71-84.

Commentary

  1. Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy (2020). In Reply. Obstetrics and gynecology, 136(3), 632.
  2. Shainker SA, Silver RM, Modest AM, Hacker MR, Hecht JL, Salahuddin S, Dillon ST, Ciampa EJ, D'Alton ME, Otu HH, Abuhamad AZ, Einerson BD, Branch DW, Wylie BJ, Libermann TA, Karumanchi S (2020). Placenta accreta spectrum: biomarker discovery using plasma proteomics. American journal of obstetrics and gynecology, 223(3), 433.e1-433.e14.
  3. Einerson BD, Nelson RE, Sandoval G, Esplin MS, Branch DW, Metz TD, Silver RM, Grobman WA, Reddy UM, Varner M, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Networ (2020). Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women. Obstetrics and gynecology, 136(1), 19-25.
  4. Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy (2020). Placenta Accreta Spectrum Disorder: Uterine Dehiscence, Not Placental Invasion. Obstetrics and gynecology, 135(5), 1104-1111.
  5. Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci K (2020). 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis & rheumatology (Hoboken, N.J.), 72(4), 529-556.
  6. Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci K (2020). 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis care & research, 72(4), 461-488.
  7. Arslan E, Branch D (2020). Antiphospholipid syndrome: Diagnosis and management in the obstetric patient. Best practice & research. Clinical obstetrics & gynaecology, 64, 31-40.
  8. Davis-Porada J, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Sawitzke A, Merrill JT, Buyon JP, Salmon J (2020). Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis research & therapy, 22(1), 52.
  9. Branch D (2019). What's new in obstetric antiphospholipid syndrome. Hematology. American Society of Hematology. Education Program, 2019(1), 421-425.
  10. Odendaal J, Quenby S, Sammaritano L, Macklon N, Branch DW, Rosenwaks (2019). Immunologic and rheumatologic causes and treatment of recurrent pregnancy loss: what is the evidence?. Fertility and sterility, 112(6), 1002-1012.
  11. Efthymiou M, Mackie IJ, Lane PJ, Andrade D, Willis R, Erkan D, Sciascia S, Krillis S, Bison E, Borges Galhardo Vendramini M, Romay-Penabad Z, Qi M, Tektonidou M, Ugarte A, Chighizola C, Belmont HM, Aguirre MA, Ji L, Branch DW, de Jesus G, Fortin PR, Andreoli L, Petri M, Cervera R, Rodriguez E, Knight JS, Atsumi T, Vega J, Sevim E, Bertolaccini ML, Pengo V, Cohen H, APS ACTIO (2019). Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository. Journal of thrombosis and haemostasis, 17(12), 2069-2080.
  12. Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A, Meroni P, Ji L, Belmont HM, Cohen H, Ramires de Jesús G, Branch DW, Fortin PR, Andreoli L, Petri M, Rodriguez E, Rodriguez-Pinto I, Knight JS, Atsumi T, Willis R, Gonzalez E, Lopez-Pedrera R, Rossi Gandara AP, Borges Gualhardo Vendramini M, Banzato A, Sevim E, Barbhaiya M, Efthymiou M, Mackie I, Bertolaccini ML, Andrade D, APS ACTIO (2019). The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort. Seminars in arthritis and rheumatism, 49(3), 464-468.
  13. Hong S, Banchereau R, Maslow BL, Guerra MM, Cardenas J, Baisch J, Branch DW, Porter TF, Sawitzke A, Laskin CA, Buyon JP, Merrill J, Sammaritano LR, Petri M, Gatewood E, Cepika AM, Ohouo M, Obermoser G, Anguiano E, Kim TW, Nulsen J, Nehar-Belaid D, Blankenship D, Turner J, Banchereau J, Salmon JE, Pascual (2019). Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy. The Journal of experimental medicine, 216(5), 1154-1169.
  14. de Jesús GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA, APS ACTIO (2019). Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study. BJOG, 126(5), 656-661.
  15. Sciascia S, Willis R, Pengo V, Krilis S, Andrade D, Tektonidou MG, Ugarte A, Chighizola C, Branch DW, Levy RA, Nalli C, Fortin PR, Petri M, Rodriguez E, Rodriguez-Pinto I, Atsumi T, Nascimento I, Rosa R, Banzato A, Erkan D, Cohen H, Efthymiou M, Mackie I, Bertolaccini ML, APS ACTIO (2019). The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis. Thrombosis research, 175, 32-36.
  16. Einerson BD, Branch D (2018). Surgical Management of Placenta Accreta Spectrum. Clinical obstetrics and gynecology, 61(4), 774-782.
  17. Zhang L, Troendle J, Branch DW, Hoffman M, Yu J, Zhou L, Duan T, Zhang (2018). The expected labor progression after labor augmentation with oxytocin: A retrospective cohort study. PloS one, 13(10), e0205735.
  18. Tebo AE, Willis R, Jaskowski TD, Guerra M, Pierangeli SS, Salmon J, Petri M, Branch D (2016). Clinical significance and correlations between anti-ß2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus. Clinica chimica acta; international journal of clinical chemistry, 460, 107-13.

Letter

  1. Barbhaiya M, Zuily S, de Jesus G, Branch DW, Erkan (2024). Reply. Arthritis & rheumatology (Hoboken, N.J.),
  2. Bruno AM, Allshouse AA, Einerson BD, Campbell HM, Branch DW, Silver RM, Metz T (2022). Trends in postpartum venous thromboembolism and chemical prophylaxis among insured US patients. American journal of obstetrics & gynecology MFM, 4(4), 100620.
  3. Harris EN, Goldsmith G, Pierangeli S, Gharavi A, Branch (1995). Phospholipid binding antibodies warrant continued investigation. Blood, 85(8), 2276-7.

News & Podcasts